Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 1.00 |
| ▸ | CA12 | O43570 | 3/20 | 1.00 |
| ▸ | CA1 | P00915 | 3/20 | 1.00 |
| ▸ | CA2 | P00918 | 3/20 | 1.00 |
| ▸ | CA3 | P07451 | 3/20 | 1.00 |
| ▸ | CA4 | P22748 | 3/20 | 1.00 |
| ▸ | CA6 | P23280 | 3/20 | 1.00 |
| ▸ | CA5A | P35218 | 3/20 | 1.00 |
| ▸ | CA7 | P43166 | 3/20 | 1.00 |
| ▸ | CA9 | Q16790 | 3/20 | 1.00 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 1.00 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | TTR | P02766 | 2/20 | 1.00 |
| ▸ | APP | P05067 | 2/20 | 1.00 |
| ▸ | AKR1B10 | O60218 | 2/20 | 1.00 |
| ▸ | AKR1B1 | P15121 | 2/20 | 1.00 |
| ▸ | DPP4 | P27487 | 2/20 | 1.00 |
| ▸ | MMP1 | P03956 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Caffeic Acid SCHEMBL23359 | 1.00 | KDM4E (1.00) | KDM4EHSD17B10CA12CA1CA2 | |
| Caffeic Acid SCHEMBL30501140 | 1.00 | KDM4E (1.00) | KDM4EHSD17B10CA12CA1CA2 | |
| Caffeic Acid SCHEMBL29447135 | 1.00 | KDM4E (1.00) | KDM4EHSD17B10CA12CA1CA2 | |
| Caffeic Acid SCHEMBL30050844 | 1.00 | KDM4E (1.00) | KDM4EHSD17B10CA12CA1CA2 | |
| Caffeic Acid SCHEMBL3682144 | 1.00 | KDM4E (1.00) | KDM4EHSD17B10CA12CA1CA2 | |
| Caffeic Acid SCHEMBL7064846 | 1.00 | KDM4E (1.00) | KDM4EHSD17B10CA12CA1CA2 | |
| Caffeic Acid SCHEMBL23358 | 1.00 | KDM4E (1.00) | KDM4EHSD17B10CA12CA1CA2 | |
| Caffeic Acid SCHEMBL1262229 | 1.00 | KDM4E (1.00) | KDM4EHSD17B10CA12CA1CA2 | |
| Caffeic Acid SCHEMBL21114743 | 1.00 | KDM4E (1.00) | KDM4EHSD17B10CA12CA1CA2 | |
| Caffeic Acid SCHEMBL9477189 | 0.98 | KDM4E (0.96) | KDM4EHSD17B10CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111787892-B | Chitosan material resistant to tissue adhesion by dissolution | 金珂生物医疗公司 | 2025-02-18 | — | — | CN | claimed |
| CN-116236491-A | Application of rhamnose in preparing medicine for treating or preventing neurodegenerative diseases, pharmaceutical composition and application thereof | 海南先声药业有限公司 | 2023-06-09 | — | — | CN | claimed |
| CN-113968795-A | Compound, composition and application of compound and composition in preparation of medicine with effect of treating myocarditis | 潍坊市人民医院(潍坊市传染病医院) | 2022-01-25 | — | — | CN | claimed |
| EP-4630006-A1 | FLOWABLE CHITOSAN BIOADHESIVE HEMOSTATIC COMPOSITIONS THAT RESIST DISSOLUTION | Tricol Biomedical, Inc. (US) | 2025-10-15 | — | — | EP | disclosed |
| WO-2025135133-A1 | AGENT FOR USE IN MAINTAINING STRUCTURE OF HYALURONIC ACID | 一丸ファルコス株式会社 | 2025-06-26 | — | — | WO | disclosed |
| CN-111787892-B | Chitosan material resistant to tissue adhesion by dissolution | 金珂生物医疗公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119371432-A | Alpha-mangostin derivative and preparation method and application thereof | 上海如凌生物医药有限公司 | 2025-01-28 | — | — | CN | disclosed |
| US-20250002490-A1 | BERBERINE SALTS, URSODEOXYCHOLIC SALTS AND COMBINATIONS, METHODS OF PREPARATION AND APPLICATION THEREOF | SHENZHEN HIGHTIDE BIOPHARMACEUTICAL LTD (CN) | 2025-01-02 | — | — | US | disclosed |
| CN-119039366-A | Keap 1-targeted glycoside compound and preparation method and application thereof | 中医药广东省实验室 | 2024-11-29 | — | — | CN | disclosed |
| CN-119032076-A | Novel compounds and uses thereof | 株式会社安提昂 | 2024-11-26 | — | — | CN | disclosed |
| WO-2024123809-A1 | FLOWABLE CHITOSAN BIOADHESIVE HEMOSTATIC COMPOSITIONS THAT RESIST DISSOLUTION | TRICOL BIOMEDICAL, INC. (US) | 2024-06-13 | — | — | WO | disclosed |
| WO-2022261201-A1 | DISSOLUTION RESISTANT TISSUE ADHERENT DRESSING APPLICATION AND ITS DELIVERY | TRICOL BIOMEDICAL, INC. (US) | 2022-12-15 | — | — | WO | disclosed |
| EP-4066302-A1 | STABLE AQUEOUS COMPOSITIONS COMPRISING QUINONES, AND USE THEREOF IN REDOX FLOW BATTERIES | Technische Universität Graz (AT) | 2022-10-05 | — | — | EP | disclosed |
| CN-105283547-B | Recombinant host cells for biosynthetic production | 罗地亚经营管理公司 | 2022-10-04 | — | — | CN | disclosed |
| WO-2022200352-A1 | USE OF ACTIVE SUBSTANCES OF PLANT ORIGIN FOR THE TREATMENT OF COVID-19 | Universität Duisburg-Essen (DE) | 2022-09-29 | — | — | WO | disclosed |
| CN-114957053-A | Oxoethylene compound or pharmaceutically acceptable salt thereof, preparation method and application thereof, pharmaceutical composition and application thereof | 中国医学科学院医药生物技术研究所 | 2022-08-30 | — | — | CN | disclosed |
| CN-114599772-A | Metal complexes and their use | 罗地亚经营管理公司 | 2022-06-07 | — | — | CN | disclosed |
| CN-114539092-A | Oat bran phenolic amide alkaloid, preparation method thereof and application thereof in preparation of itching-relieving products | 深圳海创生物科技有限公司 | 2022-05-27 | — | — | CN | disclosed |
| US-20220087952-A1 | ANTI-APICOMPLEXAN COMPOSITIONS | THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION (IL) | 2022-03-24 | — | — | US | disclosed |
| CN-113968795-A | Compound, composition and application of compound and composition in preparation of medicine with effect of treating myocarditis | 潍坊市人民医院(潍坊市传染病医院) | 2022-01-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250002490-A1 | BERBERINE SALTS, URSODEOXYCHOLIC SALTS AND COMBINATIONS, METHODS OF PREPARATION AND APPLICATION THEREOF | CYP27A1, NR1H4, CYP7A1 | KDM4E 3717/4885HSD17B10 330/4885CA12 4229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.